These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 8149355)
1. Molecular, functional and biochemical characteristics of the dopamine transporter: regional differences and clinical relevance. Hitri A; Hurd YL; Wyatt RJ; Deutsch SI Clin Neuropharmacol; 1994 Feb; 17(1):1-22. PubMed ID: 8149355 [TBL] [Abstract][Full Text] [Related]
2. [The dopamine transporter: characterization and physiopathologic implications]. Thibaut F; Vaugeois JM; Petit M Encephale; 1995; 21(6):445-51. PubMed ID: 8674469 [TBL] [Abstract][Full Text] [Related]
3. Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum. Dickinson SD; Sabeti J; Larson GA; Giardina K; Rubinstein M; Kelly MA; Grandy DK; Low MJ; Gerhardt GA; Zahniser NR J Neurochem; 1999 Jan; 72(1):148-56. PubMed ID: 9886065 [TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationship studies of 4-[2-(diphenylmethoxy)ethyl]-1-benzylpiperidine derivatives and their N-analogues: evaluation of O-and N-analogues and their binding to monoamine transporters. Dutta AK; Fei XS; Beardsley PM; Newman JL; Reith ME J Med Chem; 2001 Mar; 44(6):937-48. PubMed ID: 11300876 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and transporter binding properties of bridged piperazine analogues of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR 12909). Zhang Y; Rothman RB; Dersch CM; de Costa BR; Jacobson AE; Rice KC J Med Chem; 2000 Dec; 43(25):4840-9. PubMed ID: 11123994 [TBL] [Abstract][Full Text] [Related]
6. Development of novel, potent, and selective dopamine reuptake inhibitors through alteration of the piperazine ring of 1-[2-(diphenylmethoxy)ethyl]-and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909). Matecka D; Rothman RB; Radesca L; de Costa BR; Dersch CM; Partilla JS; Pert A; Glowa JR; Wojnicki FH; Rice KC J Med Chem; 1996 Nov; 39(24):4704-16. PubMed ID: 8941383 [TBL] [Abstract][Full Text] [Related]
7. Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter. Pristupa ZB; McConkey F; Liu F; Man HY; Lee FJ; Wang YT; Niznik HB Synapse; 1998 Sep; 30(1):79-87. PubMed ID: 9704884 [TBL] [Abstract][Full Text] [Related]
8. Pharmacological heterogeneity of the cloned and native human dopamine transporter: disassociation of [3H]WIN 35,428 and [3H]GBR 12,935 binding. Pristupa ZB; Wilson JM; Hoffman BJ; Kish SJ; Niznik HB Mol Pharmacol; 1994 Jan; 45(1):125-35. PubMed ID: 8302271 [TBL] [Abstract][Full Text] [Related]
10. Oxygenated analogues of 1-[2-(Diphenylmethoxy)ethyl]- and 1-[2-[Bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909) as potential extended-action cocaine-abuse therapeutic agents. Lewis DB; Matecka D; Zhang Y; Hsin LW; Dersch CM; Stafford D; Glowa JR; Rothman RB; Rice KC J Med Chem; 1999 Dec; 42(24):5029-42. PubMed ID: 10585212 [TBL] [Abstract][Full Text] [Related]
11. Preclinical evaluation of GBR12909 decanoate as a long-acting medication for methamphetamine dependence. Baumann MH; Phillips JM; Ayestas MA; Ali SF; Rice KC; Rothman RB Ann N Y Acad Sci; 2002 Jun; 965():92-108. PubMed ID: 12105088 [TBL] [Abstract][Full Text] [Related]
12. Rapid detection of Parkinson's disease by SPECT with altropane: a selective ligand for dopamine transporters. Fischman AJ; Bonab AA; Babich JW; Palmer EP; Alpert NM; Elmaleh DR; Callahan RJ; Barrow SA; Graham W; Meltzer PC; Hanson RN; Madras BK Synapse; 1998 Jun; 29(2):128-41. PubMed ID: 9593103 [TBL] [Abstract][Full Text] [Related]
13. Dopamine transport function is elevated in cocaine users. Mash DC; Pablo J; Ouyang Q; Hearn WL; Izenwasser S J Neurochem; 2002 Apr; 81(2):292-300. PubMed ID: 12064476 [TBL] [Abstract][Full Text] [Related]
14. Neurotensin receptors and dopamine transporters: effects of MPTP lesioning and chronic dopaminergic treatments in monkeys. Goulet M; Morissette M; Grondin R; Falardeau P; Bédard PJ; Rostène W; Di Paolo T Synapse; 1999 Jun; 32(3):153-64. PubMed ID: 10340626 [TBL] [Abstract][Full Text] [Related]
15. Dopamine D2 receptor regulation of the dopamine transporter expressed in Xenopus laevis oocytes is voltage-independent. Mayfield RD; Zahniser NR Mol Pharmacol; 2001 Jan; 59(1):113-21. PubMed ID: 11125031 [TBL] [Abstract][Full Text] [Related]
16. Dopamine transporters participate in the physiological regulation of prolactin. Demaria JE; Nagy GM; Lerant AA; Fekete MI; Levenson CW; Freeman ME Endocrinology; 2000 Jan; 141(1):366-74. PubMed ID: 10614659 [TBL] [Abstract][Full Text] [Related]
17. High affinity cocaine recognition sites on the dopamine transporter are elevated in fatal cocaine overdose victims. Staley JK; Hearn WL; Ruttenber AJ; Wetli CV; Mash DC J Pharmacol Exp Ther; 1994 Dec; 271(3):1678-85. PubMed ID: 7996484 [TBL] [Abstract][Full Text] [Related]
18. Studies of the biogenic amine transporters. VIII: identification of a novel partial inhibitor of dopamine uptake and dopamine transporter binding. Rothman RB; Dersch CM; Carroll FI; Ananthan S Synapse; 2002 Mar; 43(4):268-74. PubMed ID: 11835522 [TBL] [Abstract][Full Text] [Related]
19. Cloning of dopamine, norepinephrine and serotonin transporters from monkey brain: relevance to cocaine sensitivity. Miller GM; Yatin SM; De La Garza R; Goulet M; Madras BK Brain Res Mol Brain Res; 2001 Feb; 87(1):124-43. PubMed ID: 11223167 [TBL] [Abstract][Full Text] [Related]
20. Striatal dopamine, dopamine transporter, and vesicular monoamine transporter in chronic cocaine users. Wilson JM; Levey AI; Bergeron C; Kalasinsky K; Ang L; Peretti F; Adams VI; Smialek J; Anderson WR; Shannak K; Deck J; Niznik HB; Kish SJ Ann Neurol; 1996 Sep; 40(3):428-39. PubMed ID: 8797532 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]